Publications by authors named "Mengjia Lin"

Claim this Profile
P
Procyanidin B3 and Its Derivatives Alleviate Neuronal Injury by Targeting G3BP1 for Ischemic Stroke Therapy.
Heyanhao Zhang, Yuyu Zhang, Yibo Chen, Wen Zhong, Subei Tan, Mengjia Lin

Adv Sci (Weinh)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancers.
Juanjuan Feng, Xuanzheng Xiao, Xinting Xia, Jian Min, Weiying Tang, Mengjia Lin, Sulin Zhang

Cancer Cell· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated DBS-online SPE-LC-MS/MS platform with dynamic solvent dilution: Robust quantification of antipsychotic drugs for decentralized therapeutic drug monitoring.
Yanxiao Zhou, Huirong Li, Mengjia Lin, Jiwei Yang, Xiaofeng Yu

J Chromatogr B Analyt Technol Biomed Life Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The RNF214-TEAD-YAP signaling axis promotes hepatocellular carcinoma progression via TEAD ubiquitylation.
Mengjia Lin, Xiaoyun Zheng, Jianing Yan, Fei Huang, Yilin Chen

Nat Commun· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nontraditional translation is the key to UFMylation and beyond.
Mengjia Lin, Xiaoyun Zheng, Jianping Jin

J Biol Chem· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental and theoretical investigation of the enhancement of the photo-oxidation of Hg by CeO-modified morphology-controlled anatase TiO.
Huazhen Shen, Mengjia Lin, Lidong Wang, Zhiwei Huang, Xiaomin Wu

J Hazard Mater· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of osalmid metabolic profile and active metabolites with anti-tumor activity in human hepatocellular carcinoma cells.
Zhe Wu, Yaqiong Zhan, Li Wang, Jiepeng Tong, Li Zhang, Mengjia Lin

Biomed Pharmacother· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel multitarget kinase inhibitor BZG with potent anticancer activity in vitro and vivo enhances efficacy of sorafenib through PI3K pathways in hepatocellular carcinoma cells.
Li Wang, Yaqiong Zhan, Zhe Wu, Mengjia Lin, Xuehang Jin

Biomed Pharmacother· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis